Cipla bags Rs 1,100 crore order from South African govt

Drug major Cipla's subsidiary has bagged an order worth 2 billion rand (around Rs 1,100 crore) for HIV drugs from the South African government.

Cipla signs pact with Teva for selling drugs in South Africa

Drugmaker Cipla on Thursday announced a collaboration with Israel's Teva Pharmaceuticals for sales and distribution of the latter's drugs in South Africa.

UBS downgrades Cipla to ''sell''; shares fall

Shares of Cipla Ltd fall after UBS downgrades the stock to "sell" from "buy" and reduces its target to 370 rupees from 470 rupees citing "weak" earnings outlook despite "premium" valuations.

Cipla completes buyout of Cipla Medpro for Rs 2,707 cr

Drug major Cipla on Tuesday said it has completed the buyout process of South African pharma firm Cipla Medpro for an aggregate consideration of Rs 2,707 crore.

Expect completion of Cipla Medpro takeover by mid July: Cipla

The acquisition of South African firm would help Cipla further strengthen its position in the African continent.

Cipla receives nod from SA authorities to acquire Cipla Medpro

Drug major Cipla Ltd Thursday said it has received approval from the authorities of South African and Botswana for the USD 512 million takeover offer to acquire Cipla Medpro.

Cipla Medpro shareholders approve buyout by Cipla

Earlier this year, Cipla had offered to pay 10 rand per share to acquire 100 percent of Cipla Medpro for a consideration of around USD 512 million.

CCI to probe Cipla, 4 others for anti-competitive practices

Fair trade regulator Competition Commission is probing allegation of anti-competitive practices against five entities related to pharmaceutical industry, including drug maker Cipla.

'Cipla's offer to buy out likely to get shareholder approval'

An offer by Indian pharma giant Cipla to buy 100 percent of Cipla Medpro in South Africa is expected to be approved by shareholders at a meeting scheduled for April 30, says a top company official.

Cipla to acquire South African firm Medpro

Johannesburg-listed Medpro is South Africa's third largest generic drug firm. The board of Cipla Medpro has endorsed the deal and asked shareholders to vote for the cash offer.

Cipla offers over Rs 1,200 cr to acquire 51% in Cipla Medpro

In a filing to the BSE, Cipla said it is "in preliminary discussions and has made an indicative proposal in relation to the acquisition of an approximately 51 percent stake in Cipla Medpro South Africa Ltd".

Cipla Medpro CEO Jerome Smith quits amid misconduct charges

South Africa-based drug maker Cipla Medpro Tuesday said its chief executive Jerome Smith has quit the company.

Cipla Medpro chief executive suspended

The suspension of a top official of pharmaceutical giant Cipla Medpro will not impact relationship with Cipla in India, with which it has an supply agreement, according to the board of Cipla Medpro.